anti cd21 pe cy5 (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
94
Structured Review
Miltenyi Biotec
anti cd21 pe cy5
Anti Cd21 Pe Cy5, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd21+pe/CD21-PE/pmc12507793-76-26-42
Average 94 stars, based on 36 article reviews
Anti Cd21 Pe Cy5, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd21+pe/CD21-PE/pmc12507793-76-26-42
Average 94 stars, based on 36 article reviews
anti cd21 pe cy5 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Bioprocessing:Article Title: Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing–Remitting Multiple Sclerosis Patients Article Snippet: After erythrocyte lysis, the samples were washed and a total of 100,000 lymphocytes were acquired on a FACSCantoII flow cytometer (BD Biosciences, San José, CA, USA). .. Lymphocyte subpopulations were defined using the markers specified in Table S1, using several combinations of the following monoclonal antibodies: anti‐CD3‐AmCyan, anti‐CD4‐V450, anti‐CCR6‐phycoerythrin (PE), anti‐CCR4‐AlexaFluor 647, anti‐CD4‐allophycocyanin (APC)‐H7, anti‐CD8‐V450, anti‐CD45RA‐fluorescein isothiocyanate (FITC), anti‐CCR7‐PE‐Cy7, anti‐CD27 PerCP‐Cy5.5, anti‐CD31‐AlexaFluor 647, anti‐CD19‐PerCP‐Cy5.5, anti‐CD27‐APC, anti‐CD24‐FITC, anti‐CD38‐PE, anti‐CD19 V500, anti‐CD3‐V450, anti‐IgM‐PerCP‐Cy5.5, anti‐IgD FITC, Article Title: Distinct pattern of peripheral lymphocyte subsets in Graves' disease with persistency of anti-TSHR autoantibodies. Article Snippet: Background: Graves’ disease (GD) is characterized by the production of autoantibodies against the TSHR (TRAbs).. With long-term treatment, serum concentrations of TRAbs decline but in some patients, despite being clinically stable, TRAbs persist for many years.. Objective: To investigate whether GD patients with persistence of TRAbs constitute a subset of patients that could be identified by phenotypic analysis of circulating lymphocytes, suggesting disease heterogeneity. Software:Article Title: Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing–Remitting Multiple Sclerosis Patients Article Snippet: After erythrocyte lysis, the samples were washed and a total of 100,000 lymphocytes were acquired on a FACSCantoII flow cytometer (BD Biosciences, San José, CA, USA). .. Lymphocyte subpopulations were defined using the markers specified in Table S1, using several combinations of the following monoclonal antibodies: anti‐CD3‐AmCyan, anti‐CD4‐V450, anti‐CCR6‐phycoerythrin (PE), anti‐CCR4‐AlexaFluor 647, anti‐CD4‐allophycocyanin (APC)‐H7, anti‐CD8‐V450, anti‐CD45RA‐fluorescein isothiocyanate (FITC), anti‐CCR7‐PE‐Cy7, anti‐CD27 PerCP‐Cy5.5, anti‐CD31‐AlexaFluor 647, anti‐CD19‐PerCP‐Cy5.5, anti‐CD27‐APC, anti‐CD24‐FITC, anti‐CD38‐PE, anti‐CD19 V500, anti‐CD3‐V450, anti‐IgM‐PerCP‐Cy5.5, anti‐IgD FITC, Biomarker Discovery:Article Title: Multiplexed histology analyses for the phenotypic and spatial characterization of human innate lymphoid cells Article Snippet: .. All attempts at replication were successful for the experimental findings shown in the manuscript. n/a, because we do not compare different experimental groups n/a, because we do not compare different experimental groups For MELC: DAPI (Roche), Fibronectin (rabbit IgG; Invitrogen), anti-rabbit-PE (donkey IgG, Rockland), CD127-PE (REA279; Miltenyi), COL-IV-FITC (2F11; AntibodiesOnline), ICOS-PE (REA192; Miltenyi), Ki67-FITC (MIB1; Dako), Bcl6-PE (REA373; Miltenyi), SMA-FITC (1A4; Abcam), KLRG1-PE (REA261; Miltenyi), IRF4-PE (REA201; Miltenyi), FcER1a-PE (CRA1; Miltenyi), FoxP3-PE (PCH101; Invitrogen), NKP44-PE (2.29; Miltenyi), Pax5-PE (REA140; Miltenyi), RANKL-PE (DN254 Miltenyi), Helios-PE (22F6; Biolegend), CD123-PE (AC145; Miltenyi), Eomes-PE (WD1928; BD BioScience), CD161-PE (191B8; Miltenyi), CD16-PE (REA423; Miltenyi), CD138-PE (M115; Biolegend), CD14PE (Tük4; Miltenyi), CD141-PE (BDCA-3; Miltenyi), CD19-PE (LT19; Miltenyi), CXCR3-PE (REA232; Miltenyi), c-Kit-PE (A3C6E2; Miltenyi), CD103-PE (Ber-ACT 8; Miltenyi;), CD49a-PE (TS2/7; Biolegend), VCAM-1-PE (REA269; Miltenyi), CCR4-PE(REA279; Miltenyi), CD56-PE (AF12-7H3; Miltenyi), CD11c-PE (MJ4-27G12; Miltenyi), CD69-PE (REA824; Miltenyi), CCR5-PE (J418F1; Biolegend), CD94-PE (REA113; Miltenyi), IL1R1-PE (REA744; Miltenyi), CCR6-PE (REA190; Miltenyi), GranzA-PE (REA162; Miltenyi), IgA-PE (REA995; Miltenyi), CD200R-PE (OX-108; Biolegend), CD31-PE (9G11; R&D), IgG-PE (IS11-3B2 23; Miltenyi), Langerin-PE (REA770; Miltenyi), TCR"#-PE (REA591; Miltenyi), IgM-PE (PJ2-22H3; Miltenyi), Red Blood Cell Lysis:Article Title: A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function Article Snippet: .. After red blood cell lysis with ammonium chloride, lymphocytes were washed, resuspended in PBS, and stained with the following mouse anti-human antibodies to identify T and B cell subsets: CD45RA APC-H7 (clone T6D11; Miltenyi Biotec), CD3 PerCP (clone BW264/56; Miltenyi Biotec), CCR7 PE (clone 3D12; eBioscience), CD4 APC (clone OKT4; Becton Dickinson), CD8 PE-Cy7 (clone RPA-T8; Becton Dickinson), CD19 PE-CY7 (clone SJ25C1; Becton Dickinson), CD16 PE (clone 3G8), CD56 PE, CD27 FITC (clone M-T271, Becton Dickinson), TCR α-beta APC (clone T10B9; Becton Dickinson), TCR gamma-delta FITC (11F3; Miltenyi Biotec), Staining:Article Title: A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function Article Snippet: .. After red blood cell lysis with ammonium chloride, lymphocytes were washed, resuspended in PBS, and stained with the following mouse anti-human antibodies to identify T and B cell subsets: CD45RA APC-H7 (clone T6D11; Miltenyi Biotec), CD3 PerCP (clone BW264/56; Miltenyi Biotec), CCR7 PE (clone 3D12; eBioscience), CD4 APC (clone OKT4; Becton Dickinson), CD8 PE-Cy7 (clone RPA-T8; Becton Dickinson), CD19 PE-CY7 (clone SJ25C1; Becton Dickinson), CD16 PE (clone 3G8), CD56 PE, CD27 FITC (clone M-T271, Becton Dickinson), TCR α-beta APC (clone T10B9; Becton Dickinson), TCR gamma-delta FITC (11F3; Miltenyi Biotec), Recombinase Polymerase Amplification:Article Title: A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function Article Snippet: .. After red blood cell lysis with ammonium chloride, lymphocytes were washed, resuspended in PBS, and stained with the following mouse anti-human antibodies to identify T and B cell subsets: CD45RA APC-H7 (clone T6D11; Miltenyi Biotec), CD3 PerCP (clone BW264/56; Miltenyi Biotec), CCR7 PE (clone 3D12; eBioscience), CD4 APC (clone OKT4; Becton Dickinson), CD8 PE-Cy7 (clone RPA-T8; Becton Dickinson), CD19 PE-CY7 (clone SJ25C1; Becton Dickinson), CD16 PE (clone 3G8), CD56 PE, CD27 FITC (clone M-T271, Becton Dickinson), TCR α-beta APC (clone T10B9; Becton Dickinson), TCR gamma-delta FITC (11F3; Miltenyi Biotec), Article Title: Distinct pattern of peripheral lymphocyte subsets in Graves' disease with persistency of anti-TSHR autoantibodies. Article Snippet: Background: Graves’ disease (GD) is characterized by the production of autoantibodies against the TSHR (TRAbs).. With long-term treatment, serum concentrations of TRAbs decline but in some patients, despite being clinically stable, TRAbs persist for many years.. Objective: To investigate whether GD patients with persistence of TRAbs constitute a subset of patients that could be identified by phenotypic analysis of circulating lymphocytes, suggesting disease heterogeneity. |